CAPRICOR THERAPEUTICS, INC. Increase (Decrease) in Restricted Cash for Operating Activities
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Increase (Decrease) in Restricted Cash for Operating Activities of $1.35 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-16.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2017-03-16
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-12-31 was $745.04K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-09-30 was $602.18K.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-06-30 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for the quarter ending 2016-03-31 was $0.00.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2016 was $1.35M.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2015 was -$2.98M, a 289.00% decline from fiscal 2014.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2014 was $1.58M, a 12.36% increase from fiscal 2013.
- CAPRICOR THERAPEUTICS, INC. increase (decrease) in restricted cash for operating activities for fiscal 2013 was $1.40M.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 3 month | Increase (Decrease) in Restricted Cash for Operating Activities 6 month | Increase (Decrease) in Restricted Cash for Operating Activities 9 month | Increase (Decrease) in Restricted Cash for Operating Activities 12 month | Increase (Decrease) in Restricted Cash for Operating Activities 102 month | Increase (Decrease) in Restricted Cash for Operating Activities 105 month |
|---|---|---|---|---|---|---|
| 2016-12-31 | $745.04K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $1.35M derived: sum of 2 quarters · filed 2017-03-16 | $1.35M derived: sum of 3 quarters · filed 2017-03-16 | $1.35M 10-K · filed 2017-03-16 | ||
| 2016-09-30 | $602.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $602.18K derived: sum of 2 quarters · filed 2016-11-14 | $602.18K 10-Q · filed 2016-11-14 | $602.18K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $0.00 10-Q · filed 2016-08-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-16 | -$599.58K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2016-03-31 | $0.00 10-Q · filed 2016-05-13 | $0.00 derived: sum of 2 quarters · filed 2017-03-16 | -$599.58K derived: sum of 3 quarters · filed 2017-03-16 | -$2.05M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$599.58K derived: sum of 2 quarters · filed 2017-03-16 | -$2.05M derived: sum of 3 quarters · filed 2017-03-16 | -$2.98M 10-K · filed 2017-03-16 | ||
| 2015-09-30 | -$599.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$2.05M derived: sum of 2 quarters · filed 2016-11-14 | -$2.98M 10-Q · filed 2016-11-14 | -$3.70M derived: sum of 4 quarters · filed 2016-11-14 | ||
| 2015-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | -$2.38M 10-Q · filed 2016-08-15 | -$3.10M derived: sum of 3 quarters · filed 2016-08-15 | -$3.78M derived: sum of 4 quarters · filed 2016-08-15 | ||
| 2015-03-31 | -$929.09K 10-Q · filed 2016-05-13 | -$1.65M derived: sum of 2 quarters · filed 2016-05-13 | -$2.33M derived: sum of 3 quarters · filed 2016-05-13 | $1.49M derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | -$722.64K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | -$1.40M derived: sum of 2 quarters · filed 2016-03-30 | $2.42M derived: sum of 3 quarters · filed 2016-03-30 | $1.58M 10-K · filed 2016-03-30 | ||
| 2014-09-30 | -$678.64K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $3.14M derived: sum of 2 quarters · filed 2015-11-13 | $2.30M 10-Q · filed 2015-11-13 | $631.86K derived: sum of 4 quarters · filed 2015-11-13 | ||
| 2014-06-30 | $3.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $2.98M 10-Q · filed 2015-08-14 | $1.31M derived: sum of 3 quarters · filed 2015-08-14 | $4.38M derived: sum of 4 quarters · filed 2015-08-14 | ||
| 2014-03-31 | -$846.63K 10-Q · filed 2015-05-13 | -$2.51M derived: sum of 2 quarters · filed 2015-05-13 | $555.23K derived: sum of 3 quarters · filed 2015-05-13 | $40.01K derived: sum of 4 quarters · filed 2015-05-13 | $555.23K 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-16 | $1.40M derived: sum of 2 quarters · filed 2015-03-16 | $886.64K derived: sum of 3 quarters · filed 2015-03-16 | $1.40M 10-K · filed 2015-03-16 | $1.40M 10-K · filed 2014-03-31 | |
| 2013-09-30 | $3.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | $2.55M derived: sum of 2 quarters · filed 2014-11-14 | $3.07M 10-Q · filed 2014-11-14 | |||
| 2013-06-30 | -$515.22K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | ||||
| 2013-03-31 | $515.22K 10-Q · filed 2014-05-15 | |||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |